Accelerate Diagnostics scheduled call to review 2022 fourth quarter and full year results

Rhea-AI Summary

Accelerate Diagnostics, Inc. to host conference call to review 2022 Q4 and full year results

Positive

• Investors can listen to the audio webcast online at ir.axdx.com
• A replay of the audio webcast will be available for 30 days

Negative

• None.

TUCSON, Ariz., March 15, 2023 /PRNewswire/ -- Accelerate Diagnostics, Inc. (NASDAQ: AXDX) announced today that management will host a conference call on Wednesday, March 29, 2023, at 4:30 p.m. Eastern Time to review 2022 fourth quarter and full year results.

To listen to the audio webcast online, visit ir.axdx.com. A replay of the audio webcast will be available for 30 days.

To listen by phone, dial +1.877.883.0383 and enter the Elite Entry Number: 6648486. International participants may dial +1.412.902.6506. Please dial in 10-15 minutes prior to the start of the conference.

A replay of the call will be available by telephone at +1.877.344.7529 (U.S.) or +1.412.317.0088 (International) using the replay code 2450672 until April 19, 2023.

About Accelerate Diagnostics, Inc.

Accelerate Diagnostics, Inc. is an in vitro diagnostics company dedicated to providing solutions for the global challenges of antibiotic resistance and sepsis. The Accelerate Pheno® system and Accelerate PhenoTest^® BC kit combine several technologies aimed at reducing the time clinicians must wait to determine the most optimal antibiotic therapy for deadly infections. The FDA cleared system and kit fully automate the sample preparation steps to report phenotypic antibiotic susceptibility results in approximately 7 hours direct from positive blood cultures. Recent external studies indicate the solution offers results 1-2 days faster than existing methods, enabling clinicians to optimize antibiotic selection and dosage specific to the individual patient days earlier.

"Accelerate Diagnostics" and diamond shaped logos and marks are registered trademarks of Accelerate Diagnostics, Inc.

For more information about the company, its products and technology, or recent publications, visit axdx.com.

View original content to download multimedia:https://www.prnewswire.com/news-releases/accelerate-diagnostics-scheduled-call-to-review-2022-fourth-quarter-and-full-year-results-301772263.html

SOURCE Accelerate Diagnostics, Inc.

FAQ

When is the conference call to review 2022 Q4 and full year results?

The conference call will be held on Wednesday, March 29, 2023, at 4:30 p.m. Eastern Time

Where can investors listen to the audio webcast?

Investors can listen to the audio webcast online at ir.axdx.com

How long will the replay of the audio webcast be available?

The replay of the audio webcast will be available for 30 days

How can participants listen to the conference call by phone?

Participants can dial +1.877.883.0383 and enter the Elite Entry Number: 6648486

How long will the replay of the call be available by telephone?

The replay of the call will be available by telephone until April 19, 2023, by dialing +1.877.344.7529 (U.S.) or +1.412.317.0088 (International) using the replay code 2450672